Interested in our pipeline and platform technologies? Join me in Lisbon for three days of partnering at BIO Europe Spring. We’re actively looking for investors and co‑development...
Bio Europe Spring
read more
Interested in our pipeline and platform technologies? Join me in Lisbon for three days of partnering at BIO Europe Spring. We’re actively looking for investors and co‑development...
In collaboration with the Sorbonne University, Ksilink used both patient-derived and genome edited cellular models for desmin-related cardiomyopathy to analyze how the DESE439K...
As a member of the JUMP Cell Painting Consortium, Ksilink contributed to the perturbation of roughly 75% of the protein-coding genome in human U-2 OS cells, generating a rich...
In collaboration with the University of Luxembourg, Ksilink used a patient-derived cellular model for Parkinson’s Disease based on SNCA triplication and isogenic control mDA...
Since 2019, Ksilink has been part of the JUMP-Cell Painting Consortium, a collaboration between 10 pharmaceutical companies, six supporting technology companies, and two...
